Full-length and truncated genome segment A-specific infectious pancreatic necrosis virus cDNA was subcloned into plasmid transcription vectors, and runoff transcripts were produced in vitro. These transcripts were translated in cell-free rabbit reticulocyte lysates and the translation products were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Virus-specific polypeptides were gel purified and mapped by partial proteolysis with N-chlorosuccinimide and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Peptide profiles were compared with those of the corresponding polypeptides purified from infectious pancreatic necrosis virus-infected cells or prepared by in vitro translation of denatured genomic RNA. The cDNA directed the synthesis of authentic pVP2, VP3, and NS polypeptides as well as a number of previously undescribed polypeptides. A 101,000-molecular-weight polypeptide was isolated and shown to be the unprocessed infectious pancreatic necrosis virus polyprotein. The NS polypeptide appears to be a virus-encoded protease responsible for the cleavage of pVP2 from the polyprotein. The carboxy terminus of NS was mapped to within three or four amino acids on the polyprotein. The most likely internal translation start sites responsible for NS and VP3 production in vitro were also mapped.
Infectious pancreatic necrosis virus (IPNV) is an economically important fish pathogen and is the prototype of the newly established Birnaviridae virus family (4) . Other members of the family include infectious bursal disease virus of domestic fowl and Drosophila X virus (DXV) of Drosophila melanogaster (10) . Birnaviruses possess a bisegmented, double-stranded RNA genome contained within a mediumsized, unenveloped, icosahedral capsid (11) . Birnavirus gene expression involves the production of four unrelated major gene products which undergo various postranslational cleavages to produce three to five viral structural proteins (1, 17, 25, 26) . The largest protein, VP1, is encoded by the smaller segment B genomic RNA, whereas the remaining three major gene products are encoded by the larger segment A RNA (1, 21, 23, 25) .
Genome segment A is 3,097 base pairs long and contains a single large open reading frame (ORF) of 2,916 bases capable of encoding a 106,000 molecular-weight polyprotein (106K polyprotein) (13) . The ORF is bracketed by 5'-and 3'-terminal flanking regions (119 and 62 bases, respectively), which presumably contain sites for ribosome and RNA polymerase binding. A second small ORF in reading frame 2 (444 bases), starting with an initiation codon at 68 bases, which overlaps with the 5' end of the polyprotein ORF ( Fig.  1 ) and could encode a 17K, arginine-rich polypeptide was also identified. Neither of these predicted gene products has ever been detected in vitro or in vivo.
Recently, Hudson et al. (17) reported that the sequence of genome segment A of infectious bursal disease virus, like that of IPNV, contains a single large ORF. Thus the polyprotein mode of gene expression may be common among birnaviruses.
The order of the coding regions of the three major gene products of IPNV segment A (pVP2, VP3, and NS) on the large ORF is 5'-pVP2-NS-VP3-3' (13, 27) . The coding re-* Corresponding author.
gions on the IPNV Sp strain, infectious bursal disease virus, and Drosophila X virus large RNA segments are in the same order (16, 17, 26) . The boundaries of the coding regions of pVP2, NS, and VP3 are not known.
The discovery of the large ORF on segment A suggested that the three major gene products of this genome segment must arise by cotranslational proteolytic cleavage of a precursor polyprotein. These cleavages occur both in infected cells and during cell-free translations primed with denatured, viral genomic RNA. The location of the cleavage sites and the identity of the protease(s) involved are not known. Since the cleavages occur in vitro, it has been proposed that at least one of the virus-encoded proteins may be a protease, possibly the only nonstructural protein, the NS polypeptide (17) .
In the case of IPNV, previous in vitro translations strongly suggested that the three major gene products of IPNV genome segment A (the precursor to VP2 [pVP2], VP3, and the nonstructural polypeptide, NS) are produced by independent initiation of translation on a polycistronic mRNA (23, 27) . It would seem that, at least in vitro, IPNV is capable of generating viral polypeptides both by polyprotein processing and by independent translation initiation at internal sites. A similar situation has been reported to occur for poliovirus gene expression (12, 28) .
The purpose of this study was threefold: (i) to identify and isolate the IPNV polyprotein, (ii) to determine whether any of the three major gene products of segment A possesses proteolytic activity and is involved in polyprotein processing, and (iii) to localize the pVP2 and NS carboxy-terminal cleavage sites and the internal translation initiation sites used for NS and VP3 production in vitro. The We report here the identification and gel purification of the IPNV polyprotein. Partial peptide mapping indicates that it contains the coding regions of the major gene products and confirms that IPNV utilizes a polyprotein mode of gene expression. We present evidence indicating that NS is a virus-encoded protease responsible for the cleavage which generates pVP2 from the polyprotein. We have also localized the cleavage site which generates the carboxy terminus of NS and located what we believe represent the internal translation initiation sites used to generate the amino termini of NS and VP3 in vitro.
MATERIALS AND METHODS Cells and virus. IPNV Jasper strain (serotype 1) was grown in CHSE-214 cell monolayers and purified as previously described (10) . Viral RNA. IPNV double-stranded genomic RNA was isolated from purified virions by disruption with 1% sodium dodecyl sulfate (SDS) and incubation with 1 mg of proteinase K per ml at 37°C for 4 h followed by extensive phenol and phenol-chloroform extractions. Purified RNA was ethanol precipitated in the presence of 2.5 M ammonium acetate at -20°C and suspended in sterile TE buffer at pH 7.5 (10 mM Tris hydrochloride, 1 mM EDTA). The concentration was determined by measuring the A260, and the quality of the RNA was checked by denaturation with 10 mM methylmercury hydroxide followed by electrophoresis in 1% agarose gels containing 0.5 ,ug of ethidium bromide per ml.
Uninfected (6) . Plus-and minus-strand cDNA was size fractionated on 5 to 20% sucrose gradients (105,000 x g, 4.5 h, 20°C). Fractions containing cDNA greater than 1,500 bases long were pooled, the plus-and minus-strand cDNAs were hybridized, and truncated molecules were extended by using reverse transcriptase and the Klenow fragment of DNA polymerase I by standard procedures (22) . Double-stranded cDNA was oligo(dC) tailed and ligated into oligo(dG)-tailed pBR322 at the PstI site (22) . Recombinant plasmid DNAs containing cDNA inserts were characterized by Southern blotting (32) and probing with single-stranded IPNV cDNA. Segment A-specific clones were identified by Northern blotting (RNA blotting) of IPNV genomic RNA (33) and probing with nick-translated cDNA clones (29) . The two largest segment A cDNAs were subcloned into M13mpl9 and sequenced by a modified dideoxy chain-termination procedure (3, 9 (19) . Markers and their approximate molecular weights were phosphorylase b (94,000), bovine serum albumin (67,000), ovalbumin (43,000), carbonic anhydrase (30,000), soybean trypsin inhibitor (20, 100) , and lysozyme (14, 400) .
Purification of viral polypeptides.
[35S]methionine-labeled viral polypeptides from infected cell lysates or from in vitro translations were fractionated by SDS-polyacrylamide gel electrophoresis (PAGE) and localized by autoradiography. Specific polypeptides were excised from unstained, dried gels and recovered from reswollen gel slices by electroelution in Laemmli running buffer (19) with ISCO sample concentrator cups (Instrumentation Specialties Co., Lincoln, Neb.) for 4 h at 150 V at room temperature with the addition of 20 pLg of carrier bovine serum albumin. The electroeluted polypeptides were dialyzed against TE (pH 7.5). and the amount of trichloroacetic acid-precipitable radioactivity present in each sample was determined. The purity of the polypeptides was checked by SDS-PAGE (11% polyacrylamide gels).
Partial proteolysis with NCS. The purified polypeptides were digested with N-chlorosuccinimide (NCS; Aldridge Chemical Co., Inc., Milwaukee, Wis.), which cleaves proteins at tryptophan residues under partial proteolysis conditions (20) . Each reaction contained 150 p11 of 35S-labeled polypeptides (approximately 20 to 40 kcpm, 1 to 10 p.g of protein) in 10 mM Tris hydrochloride (pH 7.5), 0.15 g of urea, 150 .1l of glacial acetic acid, and 0.03 M NCS. Reactions were incubated at room temperature for 30 min. The reactions were stopped, and the peptides were precipitated by the addition of an equal volume of 20% trichloroacetic acid and overnight incubation at -20°C. The precipitate was recovered by centrifugation for 30 min at 4°C in a microfuge; the pellets were washed twice with ethanol-ether (1:1), suspended in 50 p.1 of electrophoresis sample buffer, and boiled. Peptides were fractionated by SDS-PAGE (15%/ polyacrylamide gels); the gels were stained with Commassie blue, destained, treated with En3Hance (New England NItclear) for fluorography, dried, and exposed on Kodak XAR X-ray film at -70°C for 3 to 10 days. The same molecular weight markers were used as for 11% gels with the addition of RNase A (13,700 molecular weight) and RNase TI (11,100 molecular weight). The gel molecular weight estimates of the NCS-treated peptides were reduced by 5% to account for peptide oxidation (20) . The 5% estimate was determined by comparing the mobilities of untreated, purified polypeptides with the mobilities of the corresponding NCS-treated, undigested polypeptides.
Computer analysis of the cDNA sequence. The cDNA sequence was analyzed on an IBM-PC computer by using the software programs of Schwindinger and Warner (31) and Mount and Conrad (24) .
RESULTS
Isolation of the IPNV polyprotein. To identify the IPNV polyprotein we subcloned full-length clones and various truncated segment A-specific cDNA clones from M13mp19 into the transcription vectors pGEM1 and pGEM2. Linearized vectors were used as templates to produce the runoff transcripts, which were translated in vitro; the products were analyzed by SDS-PAGE (Fig. 2) .
Translation of the minus-sense mRNA (from pG1.31, bases 1 through 3097) produced no polypeptides other than those produced by endogenous mRNA (data not shown).
Translation of full-length, plus-sense mRNA (from pG2.31, bases 1 through 3097) produced several polypeptides not present in endogenous translations (lanes 31 in Fig. 2 Fig. 1) showing the regions contained in the clones pG2.31 and pG1. 27. nine other polypeptides of various sizes were produced which did not correspond to any previously described IPNV gene products. They are identified by their gel molecular weight estimates in Fig. 2 .
The largest product detected was a polypeptide with an estimated molecular weight of 101,000 (PP in Fig. 2 ), in good agreement with the size estimate of the predicted IPNV polyprotein (106,000 molecular weight). This polypeptide migrated above VP1, the gene product of genome segment B, which is the largest previously identified IPNV gene product. Some translations primed with denatured, genomic RNA produced a very faint product which comigrated with the 101K polypeptide, although it was not usually evident.
Translation of the 5'-terminal truncated mRNA (from pG1.27, bases 351 through 3097) yielded the same polypeptides as those obtained with full-length mRNA, except for pVP2 and the 101K polypeptide (Fig. 2) . Transcripts derived from this clone contained a 5'-terminal deletion, to the internal EcoRI site at 351 base pairs, and lacked methionine codons 1 and 2 (Met-1 and Met-2) of the large ORF (see Fig. 4A for the locations of the in-phase methionine codons). These results confirmed the mapping of pVP2 to the 5' end of the RNA and indicated that the 101K product was probably the predicted IPNV polyprotein which must initiate at Met-1 or Met-2 of the large ORF. The 67K polypeptide could not always be easily detected from pG1.27, and its intensity varied considerably in different preparations, even with pG2.31. Low-molecular-weight (14,000 to 20,000) polypeptides present also in the 5'-truncated mRNA translation (pG1.27) could not have arisen from translation of the second small ORF in reading frame 2. We have not been able to detect the predicted 17K product of the small ORF in vivo or in vitro.
The relative amounts of the various translation products varied with the source of the RNA, the translation kit, and the K+ concentration (Fig. 2) . Translations with the New England Nuclear kits were routinely done at a K+ concentration of 50 mM to enhance the translation of uncapped mRNA (2) .
Denaturation of the T7 mRNA with 10 mM CH3HgOH before translation or the addition of placental RNase inhibitor to 3 U/ul in the translation mixture did not affect the polypeptide profile (data not shown). Incubation of the translation mixture at 30°C, which reportedly can increase the production of larger polypeptides (7), did not affect the quality or quantity of the translation products. blocked amino terminus (unpublished observation), we attempted to map the amino terminus of VP3 by identifying the internal translation initiation site with a truncated cDNA NS--*" -30
clone.
The 5'-proximal methionine codon in clone pG1.8 (bases 2351 through 3097) was met-18 (2,364 bases in the large ORF), which is contained in a perfect Kozak consensus sequence for a eucaryotic translation initiation site (CCAC CATGG) (18) and seemed a likely candidate for the VP3 X -1 4 translation initiation site.
Translation of pG1.8-derived transcripts produced one t37 dominant translation product in large amounts which as a -11.1 29K polypeptide is smaller by approximately 2,000 daltons than authentic VP3 (Fig. 4A ), but with a similar NCS sof selected IPNV digestion profile of VP3 (Fig. 4B ). This polypeptide was lyacrylamide gels).
purified from gels and digested with NCS. The peptide ere obtained from profile was compared with the VP3 peptide profile (Fig. 4B ). lations primed with This translation product clearly represented a truncated 7 transcripts (lanes VP3. The X's in Fig. 4B Figure 3 illustrates the peptide profiles of pVP2, VP3, and NS obtained from T7 transcripts, denatured genomic RNA, and IPNV-infected cells compared with the peptide profile of the 101K polypeptide from T7 transcripts. Each profile of the three major IPNV gene products was unique except for the presence of a 14,000-to 15-molecular-weight peptide in both the NS and VP3 patterns (Fig. 3, lanes NS and VP3) .
The same nine major peptides of pVP2 and the three major cleavage peptides of VP3 were all present in the putative polyprotein cleavage pattern. Extra bands for the polyprotein presumably represent peptides which span the pVP2-NS-VP3 junctions.
The NCS-treated peptide patterns of each of the major gene products were identical regardless of the source of the polypeptide (e.g., NS from infected cells and from in vitro translation of T7 mRNA and genomic RNA Peptides with gel estimated molecular weights of 24,000, 22,000, and 15,000 are present in both the pG1.31 and pG1.8 VP3 products (Fig. 4B ). These peptides of VP3 presumably correspond to the 23.1K, 21.5K, and 15.4K internal peptides. The 30K (uncut VP3) polypeptide and the 12K peptide showed faster electrophoretic mobilities (lane 8) than the corresponding peptides of full-length VP3 (lane 31), with estimated molecular weight reductions of 1,000 to 1,500. These peptides presumably represent the amino- terminal peptides (26.7K and 11.3K), indicating that VP3 produced by pG1.8 was amino truncated. This indicated that Met-18 is not the internal translation initiation site used for VP3 production in vitro.
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These data suggested that Met-16 or Met-17 (2307 or 2328 bases, respectively) must represent the internal translation initiation site for VP3. The NCS peptide profiles were inconsistent with translation initiation at any other methionine codon. Translation initiation at Met-16 or Met-17 would produce VP3 polypeptides with molecular weights of 27,400 or 26,700, respectively. Since gel molecular weight estimates are not sufficiently precise to distinguish between these two possibilities, we cannot conclusively state whether Met-16 or Met-17 is used for VP3 production in vitro. We compared the sequence surrounding Met-1, the start site of pVP2 and probably the polyprotein, with the sequence surrounding Met-17 (Fig. 6) . The sequences flanking Met-1 and Met-17 have approximately a 55% sequence homology, whereas there is less than 17% sequence homology between Met-land Met-16-flanking sequences with no conserved groups of nucleotides (data not shown). In view of the sequence conservation around Met-17 we propose that Met-17 is the most likely internal translation initiation site for VP3 production in vitro.
Detection of a viral protease and fine-structure mapping of its coding region. To map the boundaries of the NS-coding region, we prepared two cDNA fragments containing 3'-terminal plus-strand truncations, pG2.21 (1 to 2,198 bases) and pG1.22 ( to 2,281 bases) (Fig. 7) . mRNA produced from these clones should yield pVP2 and either a full-length or carboxy-terminal truncated NS depending on where the NS-coding region ends. Figure 7 shows the translation products produced by these clones. Clone pG2.21 gave an unexpected polypeptide pattern. The dominant product had a gel molecular weight (Fig. 7) . In addition, the 49K and 37K polypeptides, which are also produced by genomic RNA in vitro (Fig. 2) , were produced in normal amounts.
The pVP2, 49K, 37K, and NS polypeptides from pG1.22 and the 80K product from pG2.21 were gel purified and digested with NCS. The peptide profiles were compared to the profiles of the corresponding polypeptides produced by full-length RNA (pG2.31) (Fig. 8) . The peptide profile of the 80K product of pG2.21 contained the nine major peptides of pVP2 in addition to some extra higher-and lower-molecularweight peptides, indicating that it represented the unprocessed, truncated polyprotein.
The pVP2, 49K, and 37K polypeptides produced by pG1.22 were indistinguishable from the corresponding polypeptides produced by pG2.31 (Fig. 8) . Since the NS of pG1.22 was slightly smaller than authentic NS by approximately 500 daltons, the carboxy terminus of the NS-coding region must be encoded by the region immediately after the PstI site at 2276 bases, the 3' end of pG1.22. The data also indicated that NS is involved in the cleavage that generates the carboxy terminus of pVP2, which is presumably the same terminus as the termini of the 49K and 37K polypeptides, suggesting that NS is a virus-encoded protease. The production of the pVP2, 49K, and 37K polypeptides was dependent on the presence of a functional NS gene product. An analysis of the 49K and 37K NCS-treated peptide patterns (Fig. 8 ) revealed that these two polypeptides are most likely derived by cleavage of the 95K and 89K polypeptides at the pVP2-NS cleavage site (data not shown). The 95K and 89K polypeptides are derived by translation initiation at downstream methionine codons (see pG1.27 in Fig. 2) , most probably Met-3 and Met-5 (543 and 696 bases, respectively), and thus represent amino-terminally truncated polyproteins. The 49K and 37K polypeptides would therefore represent amino-terminally truncated pVP2 polypeptides.
Knowing the location of the carboxy terminus of NS, we used gel molecular weight estimates of NS to determine which methionine codon serves as the internal translation initiation site for NS production in vitro.
Gel molecular weight estimates of NS range from 27,000 to 29,000. Using the internal NCS-digested peptides of VP3 (Fig. 4B) as internal molecular weight standards on a 15% polyacrylamide gel and extrapolating, we obtained a molecular weight estimate for NS of 26,000, slightly smaller than the estimate of 28,000 molecular weight obtained with external standards. There are only two in-phase methionine codons (Met-10 and Met-11) (1,515 and 1,629 bases, respectively) that could serve as initiation codons to generate a polypeptide in the expected size range (27, If, however, NS is autocatalytic, it might recognize the same dipeptide at the pVP2-NS and NS-VP3 cleavage site. The only dipeptide occurring once at either side of the NS sequence is a Tyr-Leu dipeptide (Fig. 5) . Further work should enable us to ascertain whether it constitutes the cleavage site.
The polyprotein and the other high-molecular-weight in vitro products (Fig. 2) were not detected in translations of genomic RNA. These products should be produced by genomic RNA in vitro, since genomic RNA directs the production of pVP2, 49K, and 37K, which are cleavage products of these larger precursors. This may reflect the presence of a slightly altered NS with reduced protease activity produced by the T7 polymerase transcripts. The cDNA sequence, obtained from two independently isolated clones, revealed two base discrepancies between the two clones at positions 1816 and 2190. A-to G-transitions were discovered which result in amino acid changes in the NScoding region (Glx-Gly and Gly-Arg). The genomic RNA has not been sequenced over these regions, and we do not know which amino acid reflects the correct sequence of the polyprotein in vivo. The clones used in this study were obtained from the clone containing a glutamic acid codon at 1,816 bases and a glycine codon at 2,190 bases. If either of these codons did not represent the correct sequence of the genomic RNA, then the T7-derived transcripts could conceivably produce an NS with reduced proteolytic activity.
We have succeeded in localizing the boundaries of the NSand VP3-coding regions. The VP3-coding region presumably ends at the termination codon of the polyprotein ORF at 3,035 bases. We have determined that ribosomes preferentially use Met-16 or Met-17 to initiate VP3 translation in vitro. The sequences flanking Met-17 show sequence conservation with the sequences flanking Met-1 (Fig. 6) , the start site of the polyprotein. In particular, 5 to 10 bases upstream there is a conserved 5'-ATC-3' triplet, the same sequence found preceding the vesicular stomatitis virus ribosome-binding sites (15) . Approximately 10 to 20 bases upstream there is a conserved 5'-AACAA-3' sequence. At about the same distance upstream of the vesicular stomatitis virus ribosome-binding sites for the N and P genes, there is a conserved 5'-AACAG-3' sequence (15). Sargan et al. (30) determined a consensus eucaryotic translation initiation site sequence based on an analysis of 162 mRNAs (ATCCAC C(X)nATG). The Kozak consensus sequence (CCAC CATGG) is actually a subset of this sequence. We were interested to note the presence of the ATC triplet in this consensus sequence, which also precedes the vesicular stomatitis virus N-and P-protein translation initiation sites (15) and is found in the sequence preceding Met-1 and Met-17 of IPNV (Fig. 6) . Due to the sequence surrounding Met-17, we believe that Met-17 is the most likely candidate for the VP3 internal translation initiation site.
Similarly, the data indicate that Met-11 is the only methionine codon which would produce an NS, terminating within three or four amino acids of the region encoded by the PstI site at 2,276 bases, with a predicted NCS cleavage pattern consistent with that observed for both in vivo-and in vitro-derived NS.
We found that the production of NS from either T7 transcripts or genomic RNA was highly variable, whereas VP3 was always the dominant product produced. This suggests that NS production may be more sensitive to environmental conditions. A similar situation has been reported to occur during in vitro translation of the Sendai virus P/C mRNA (8) , where three alternate translation initiation sites on this mRNA were shown to function in vivo and in vitro at different levels. These workers reported that the ratios of some of the products synthesized in vitro varied with the source of the reticulocyte lysate, and they proposed that the salt concentration and possibly RNA secondary structure might be involved in ribosome initiation. A similar situation might explain the variable production of NS in vitro.
The production of several high-molecular-weight polypeptides from segment A indicated that ribosomes were initiating at multiple sites on the IPNV RNA (Fig. 2) . None of these high-molecular-weight products has yet been detected in vivo, and their biological significance remains unclear. Similarly, it is presently unclear whether the internal translation initiation sites we have mapped in this study, which are used for NS and VP3 production in vitro, also function in vivo. This is an important question, since it has profound implications for both IPNV gene expression and eucaryotic translation in general.
There are several reports in the literature of other viruses that appear to initiate translation at methionine codons located a considerable distance from the 5' end of the RNA.
The vesicular stomatitis virus phosphoprotein (P protein) mRNA also produces a 7K protein from the 3'-proximal region of the RNA by internal translation initiation at a downstream, in-phase methionine codon (15) . This site also appears to function in vivo. The adenovirus type 2 polymerase gene encodes the 140K DNA polymerase (AdPol) and a 62K polypeptide produced by internal translation initiation in vitro at the 11th or 12th in-phase methionine codon (1, 638 or 1,655 bases). Evidence suggests this site may function in vivo as well (14) .
A situation very similar to our results reported here involves the production in vitro of two polyproteins (105K and 95K) from cowpea mosaic virus genome segment M RNA by translation initiation at two sites (34) . Recent evidence obtained with antiserum raised against synthetic peptides present near the amino terminus of both polyproteins indicates that the downstream initiation site also functions in vivo (34 
